Glucotrol XL Related Clinical Trials
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans [Recruiting]
A Study of MK-3102 in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019 AM2) [Recruiting]
Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets [Completed]
Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia [Recruiting]
Efficacy and Safety Study of Alogliptin Compared to Glipizide in Elderly Diabetics [Recruiting]
Sitagliptin vs Glipizide in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency [Recruiting]
Sitagliptin vs Glipizide in Patients With Type 2 Diabetes Mellitus and End-Stage Renal Disease [Recruiting]
Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients [Recruiting]
Food Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg [Completed]
Fasting Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg [Completed]
Novofine Autocover Safety Needle Versus BD Safety Glide [Completed]
Sitagliptin (MK0431) Versus Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone [Recruiting]
Study on the Prognosis and Effect of Anti-Diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease [Active, not recruiting]
MK0767 Glipizide Comparator Cardiac Safety Study [Completed]
An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus [Completed]
TARGET: Insulin Glargine in Type 2 Diabetic Patients [Active, not recruiting]
An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency [Completed]
Ginkgo Biloba Extract and the Insulin Resistance Syndrome [Completed]
Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis [Recruiting]
Dyslipidemia in Type 2 Diabetes [Completed]
Standard Medical Management in Secondary Prevention of Ischemic Stroke in China [Recruiting]
|